Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97354349

Filing Date: 04/08/2022

To the Commissioner for Trademarks:

MARK: COMPLETE (Standard Characters, see mark)
The literal element of the mark consists of COMPLETE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, AbbVie Biotechnology Ltd, a corporation of Bermuda, having an address of
      Thistle House, 4 Burnaby Street
      Hamilton, Pembroke HM11
      Bermuda
      847-937-3386(phone)
      847-938-2623(fax)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 041:  Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments thereof

In International Class 041, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/01/2013, and first used in commerce at least as early as 01/01/2013, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Digital images of website pages of three different products showing mark in uase..

Original PDF file:
SPE0-159180140142-2022040 8152839657176_._Savings_a nd_Support___QULIPTA_Comp lete.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Original PDF file:
SPE0-159180140142-2022040 8152839657176_._Skyrizi_C omplete___Patient_Support ___Resources.pdf
Converted PDF file(s) (9 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Original PDF file:
SPE0-159180140142-2022040 8152839657176_._HUMIRA_Co mplete___Patient_Resource s___Support.pdf
Converted PDF file(s) (6 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Webpage URL: http://www.qulipta.com/savings-support/qulipta-complete-savings-program
Webpage Date of Access: 04/08/2022
Webpage URL: http://www.skyrizi.com/skyrizi-complete/about-skyrizi-complete
Webpage Date of Access: 04/08/2022
Webpage URL: http://www.humira.com/humira-complete
Webpage Date of Access: 04/08/2022

International Class 042:  Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/01/2013, and first used in commerce at least as early as 01/01/2013, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Digital images of website page for three different sites for our products showing mark in use..

Original PDF file:
SPE0-1-159180140142-20220 408152839657176_._Savings _and_Support___QULIPTA_Co mplete.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Original PDF file:
SPE0-1-159180140142-20220 408152839657176_._Skyrizi _Complete___Patient_Suppo rt___Resources.pdf
Converted PDF file(s) (9 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Original PDF file:
SPE0-1-159180140142-20220 408152839657176_._HUMIRA_ Complete___Patient_Resour ces___Support.pdf
Converted PDF file(s) (6 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Webpage URL: http://www.qulipta.com/savings-support/qulipta-complete-savings-program
Webpage Date of Access: 04/08/2022
Webpage URL: http://www.skyrizi.com/skyrizi-complete/about-skyrizi-complete
Webpage Date of Access: 04/08/2022
Webpage URL: http://www.humira.com/humira-complete
Webpage Date of Access: 04/08/2022



The owner's/holder's proposed attorney information: Matthew O. Brady. Other appointed attorneys are Cheryl A. Withycombe. Matthew O. Brady of AbbVie Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Mail code: AND-250C
      18655 Teller Avenue
      Irvine, California 92612
      United States
      847-937-3386(phone)
      847-938-2623(fax)
      mbrady@abbvie.com
The docket/reference number is ABVT70730.
Matthew O. Brady submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Matthew O. Brady

PRIMARY EMAIL FOR CORRESPONDENCE: mbrady@abbvie.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@abbvie.com; kimberly.gleason@abbvie.com; cheryl.withycombe@abbvie.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /mob/   Date: 04/08/2022
Signatory's Name: Matthew O. Brady
Signatory's Position: Vice President
Signatory's Phone Number: 714-246-4788
Signature method: Signed directly within the form
Payment Sale Number: 97354349
Payment Accounting Date: 04/08/2022

Serial Number: 97354349
Internet Transmission Date: Fri Apr 08 15:41:54 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20220408154154
619148-97354349-82011d66ea9327e8765a01db
2238656d52c7a67564687893778050356c36b16f
dd-DA-41541927-20220408152839657176